A phase I study of novel dual Bcl-2/Bcl-xL inhibitor APG-1252 in patients with advanced small cell lung cancer (SCLC) or other solid tumor.

出版年份 2018 全文链接

标题

作者

关键词

出版物

JOURNAL OF CLINICAL ONCOLOGY

Volume 36, Issue 15_suppl, Pages 2594-2594

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2018-09-05

DOI

10.1200/jco.2018.36.15_suppl.2594

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

JOURNAL OF CLINICAL ONCOLOGY

向作者/读者发起求助以获取更多资源

Protocol

Reagent

Reprint

Discover Peeref hubs

Publish scientific posters with Peeref